The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells

The ubiquitin-proteasome system is elementary for cellular protein degradation and gained rising attention as a new target for cancer therapy due to promising clinical trials with bortezomib, the first-in class proteasome inhibitor meanwhile approved for multiple myeloma and mantle cell lymphoma. Bo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neoplasia
Glavni autori: Schmidt, Moritz, Altdörfer, Vanessa, Schnitte, Sarah, Fuchs, Alexander Rolf, Kropp, Korbinian Nepomuk, Maurer, Stefanie, Müller, Martin Rudolf, Salih, Helmut Rainer, Rittig, Susanne Malaika, Grünebach, Frank, Dörfel, Daniela
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press 2019
Teme:
Original article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6538843/
https://ncbi.nlm.nih.gov/pubmed/31132676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2019.03.001
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items